Ronald P. Danis
About
In The Last Decade
Ronald P. Danis
163 papers receiving 6.7k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Ophthalmology 5.7k
- Radiology, Nuclear Medicine and Imaging 4.0k
- Molecular Biology 1.1k
- Epidemiology 546
- Endocrinology, Diabetes and Metabolism 373
Countries citing papers authored by Ronald P. Danis
This map shows the geographic impact of Ronald P. Danis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald P. Danis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald P. Danis more than expected).
Fields of papers citing papers by Ronald P. Danis
This network shows the impact of papers produced by Ronald P. Danis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald P. Danis. The network helps show where Ronald P. Danis may publish in the future.
Co-authorship network of co-authors of Ronald P. Danis
This figure shows the co-authorship network connecting the top 25 collaborators of Ronald P. Danis. A scholar is included among the top collaborators of Ronald P. Danis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald P. Danis. Ronald P. Danis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Spectral Domain-Optical Coherence Tomography in Tracking Progression of Geographic Atrophy in Individuals with Late-Stage Age-Related Macular Degeneration | 1 |
| 2 | Choroidal Changes after Suprachoroidal Injection of CLS-TA, Triamcinolone Acetonide Injectable Suspension, in Eyes with Macular Edema Secondary to Retinal Vein Occlusion | 1 |
| 3 | 12 | |
| 4 | Index of Non Circularity as a Predictor for Progression in Eyes with Geographic Atrophy (GA) | 1 |
| 5 | 32 | |
| 6 | Intensive Diabetes Therapy Reduces Ocular Surgeries in Patients with Type 1 Diabetes: twenty-eight year followup of the Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC) | 2 |
| 7 | 9 | |
| 8 | 26 | |
| 9 | 193 | |
| 10 | Changes From Baseline to One Year in Fundus Autofluorescence (FAF) Images in the Age-Related Eye Disease Study 2 (AREDS2) | 1 |
| 11 | Comparison of Fundus Autofluorescence Images to Digital Color Images for RPE Atrophy in AREDS2 | 1 |
| 12 | Angiographic Results of the ANCHOR Study of Ranibizumab in Neovascular Age-Related Macular Degeneration: Reading Center Evaluation of Angiographic Data | 1 |
| 13 | 49 | |
| 14 | Association of Calcified Drusen With Progression of AMD in AREDS Participants | 3 |
| 15 | The Analytic and 12–Month Biological Variability of Retinal Oximetry Measurements in Patients With Non–Neovascular Age Related Macular Degeneration | 1 |
| 16 | Reticular Drusen as a Baseline Risk Factor for Progression to Advanced AMD in AREDS | 1 |
| 17 | Photodynamic Therapy with Verteporfin combined with Intravitreal Triamcinolone Acetonide for the treatment of Choroidal Neovascularization | 1 |
| 18 | 37 | |
| 19 | 22 | |
| 20 | 57 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.